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Abstract 
Background: Measles caused by a paramyxovirus, characterized by fever, malaise, cough, coryza conjunctivitis, a 
maculopapular rash is known to result in pneumonia, encephalitis and death. Fatal cases of measles in Sri Lanka are rare 
after implementation of the National Immunization Programme in 1984. Thereafter 0.1% case fatality rate was observed 
during October 1999–June 2000 which is a very low figure compared to other regional countries. Immunization guide-
lines were further revised in 2001, 2011 and in 2012 when additional immunization was recommended to age group 
4–21 years; who are likely to have inadequate immunization, in order to achieve elimination of Measles by 2020. How-
ever, in 2013–2014, 4690 cases were reported and the majority were children less than 1 year of age. The occurrence 
in adults is hard to retrieve in published epidemiological reports, however had been 38% (out of 1008 patients) in the 
3rd quarter of 2013. During this outbreak 73/101 (72%) reported from the North Central Province of Sri Lanka had been 
more than 12 years of age with 50% being more than 29 years. 14 Sri lankan adult patients [median age 32 years (range 
25–48)] who presented sporadically from June 2014 to March 2016, with confirmed measles infection were enrolled 
retrospectively after informed consent. Details with regards to their clinical presentation, immunization and other rel-
evant areas were collected using an interviewer administered questionnaire or using patient management records.
Results: The patients presented with high fever, headache, severe body aches, sore throat, dry cough, intense tear-
ing, red eyes and posterior cervical lymphadenopathy over 3–5 days duration. Later they developed discrete macu-
lopapular rash helping the diagnosis. They had a variable degree of leucopenia, lymphocytosis, thrombocytopenia 
and derangements in the liver functions mimicking any other acute febrile illnesses such as dengue, chikungunya, 
leptospirosis or Zika virus infection.
Conclusion: At least a 3–5 day delay in the diagnosis was observed (even after the appearance of the rash in some 
patients), due to non-awareness of its occurrence, unfamiliarity of measles in adults, non-specific nature of the illness 
and non-availability of rapid diagnostics, risking transmission to the immune-compromised or non-immune staff or 
patients. Identification of the source of infection in these sporadic adult cases and their virologic surveillance and 
molecular epidemiology will be important to interrupt the transmission and to achieve the targeted elimination of 
measles from Sri Lanka by 2020.
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Background
Measles is an acute febrile illness caused by a virus 
that belongs to the family paramyxovirus in the genus 
Morbillivirus. It is characterized by fever (as high as 
105  °F) malaise, cough, coryza, and conjunctivitis, fol-
lowed by a maculopapular rash [1]. The rash usually 
appears 14 days after exposure and on the 3rd–5th day of 
clinical illness which spreads from head to trunk to lower 
extremities [2]. Measles is usually a mild or a moderately 
severe illness. However, measles can result in complica-
tions such as pneumonia, encephalitis and death. Post 
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infectious encephalitis may occur in approximately one 
per 1000 reported measles cases. [3, 4]. In Childhood 
measles, approximately two to three deaths may occur for 
every 1000 reported measles cases [4].
The annual incidence of measles in Sri Lanka dur-
ing 1951–1960, 1961–1970 and 1971–1980 varied 
from about 20 to 47,18 to 38 and 12 to49 per 100,000 
population respectively [5]. In 1982, this figure rose to 
87/100,000 population. Following this outbreak, measles 
vaccine was introduced into the Expanded Programme 
of Immunization (EPI) of Sri Lanka in 1984, with rec-
ommendations to be administered at 9  months of age 
[5]. Morbidity and mortality of measles were reduced 
remarkably since then and by 1998, the prevalence rate 
was 0.5/100,000 population [5]. However, from October 
1999 to June 2000, 15,204 suspected cases of measles 
were reported [5]. Among the clinically confirmed cases, 
114/100,000 population occurred in less than 9-month-
old age group followed by 81/100,000 population in the 
15 to 19-year-old age group. Nearly 54% of the cases 
were above 15-year-old age suggesting a gradual shift of 
the disease to the older age groups [5]. During this out-
break, vaccination history was available in 3728 clinically 
confirmed cases. Of them 60% had not been vaccinated; 
10% in the 5 to 9 year-old age group, and 38% in the 10 
to 14-year-old age groups and of those who were above 
15 years of age,more than 80% had not been vaccinated 
against measles [5]. There were 5 deaths, giving a case-
fatality rate of 0.1% [5]. The ages of those who died were 
9 months and 4, 5, 17, and 24 years. Therefore, it was sug-
gested that despite high immunization coverage, addi-
tional susceptible persons could be expected to join this 
non-immune cohort because the vaccine is only 85% 
effective [3, 4, 6]. Therefore, a second dose of measles vac-
cine was introduced to all children at the age of 3 years 
since 2001 in combination with rubella vaccine [MR 
(Measles and Rubella vaccine)]. In 2011 however MMR 
[Mumps, Measles and Rubella] vaccine was introduced at 
the age of 1  year and 3  years replacing measles vaccine 
at 9 months and MR vaccine at 3 years [7]. Furthermore, 
in March 2012, an additional immunization programme 
was instituted to cover the age group 4–21  years with 
view to cover all those who are likely to have had no 
or single dose immunization [7]. This is because, the 
“Revised Measles, Rubella, Congenital rubella syndrome 
elimination targets: September 2015” intends to elimi-
nate measles from Sri Lanka by the year 2020 [8]. After 
12 years of introduction of MR vaccine, from 2nd quarter 
of 2013 to 1st quarter of 2014, an island wide outbreak of 
nearly 4690 cases were reported from the country [9]. Of 
which, nearly 26% had been in the less than 1 year of age 
and nearly 38% had been in the age >12 years [10]. Dur-
ing this outbreak, 101 measles suspects were reported 
from Anuradhapura Teaching Hospitalin North Central 
Province of Sri Lanka, and 73/101 (72%) of them had 
been more than 12  years of age. Of the 73, nearly half 
were more than the age 29 years. Authors suggest change 
in the immunization schedule in 2012 as triggering factor 
for this outbreak [11].
During the period, June 2014 to March 2016, 110 
patients with measles were reported from the Colombo 
North Teaching Hospital (CNTH), Ragama, Sri Lanka 
and included 68 patients less than 12  years of age and 
42 above 12  years of age (unpublished hospital data). 
Of them, we report clinical and demographic data of 12 
adults with measles who presented to the Professorial 
Medical Unit of CNTH and 2 patients who were admit-
ted to a Private hospital in Ragama in order to highlight 
several considerations that was thought important when 
dealing with adult patients with measles infection.
Methodology
A retrospective study was carried out recruiting 14 adult 
patients with confirmed measles infection who were 
managed at the Professorial Medical Unit, Colombo 
North Teaching Hospital, Ragama, Sri Lanka during June 
2014 to March 2016. Demographic and clinical data were 
retrieved retrospectively using a predesigned question-
naire with the help of ward records. Some other relevant 
data were later obtained by interviewing patients during 
their clinic visits and by telephone conversations.
Results
Fourteen adult patients;8 males,with median age 
32(range 25–48) years,presented with high fever, head-
ache, severe body aches, a severe sore throat and a dry 
cough for 2–3 days duration. They complained of severe 
sore eyes around the 4–5th day associated with intense 
tearing. Examination revealed variable degree of poste-
rior cervical lymphadenopathy and in 6 of them, typical 
Koplik’s spots were noted in the buccal mucosa on the 
3–4th day of illness. The eyes were injected around the 
4th day and progressed to develop red eyes over the next 
few days (Fig. 1). Five of them developed sub-conjuncti-
val haemorrhages. The patients with severe conjunctivitis 
had photophobia and intense tearing requiring treatment 
by ophthalmologists. Around the 5th day of clinical ill-
ness, they developed a discrete maculopapular rash start-
ing in the forehead and the face which spread to involve 
the upper chest, back and the limbs including palms and 
soles by the 7th day (Fig. 2). Almost all patients developed 
a dry cough on the 3rd day and 8 developed severe intrac-
table cough and wheezing with the chest examination 
revealing wide spread coarse crackles and polyphonic 
rhonchi. In investigations on 3rd–4th day; the white cell 
count ranged 2.2–6.2 × 103/dL with neutrophils ranging 
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34–53% and lymphocytes 35–55%. The lowest platelets 
ranged 96–152  ×  109/L. The C-reactive protein levels 
(CRP) ranged from 14 to 56  mg/dl. Almost all of these 
patients had derangements in the liver functions with 
ALT (Alanine aminotransferase) median (range) 246iu/L 
(128–367) and AST (Aspartate aminotransferase)178iu/L 
(96–236) with normal serum bilirubin and alkaline phos-
phatase levels. Around the 5–7th day, eight patients had 
coarse crackles wide spread over the lung fields, rises in 
the white cell counts (9.3–11.5  ×  103/dL; N 65–78%), 
high CRP levels (24–110  mg/dL) and chest radiographs 
showing bilateral patchy opacifications (2–5  mm) sug-
gestive of varying degrees of lower respiratory tract 
involvement and required management with intravenous 
cephalosporins (cefuroxime or cefotaxime). Altogether, 
the illness lasted up to about 10 days and had high fever 
spikes ranging from 102 to 104 °F for about 6–7 days in 
a majority of cases. The fever regressed with the fading 
of the rash and was followed by peeling of the facial skin 
and the palms and soles. All 14 patients were positive for 
measles IgM antibodies confirming the diagnosis. They 
were negative for dengue NS1 Ag. On further question-
ing none of these patients knew whether they had mea-
sles immunization as a child nor had immunization 
records available with them. Furthermore, they were 
not aware of recent recommendation of immunization 
for those who were above 25  years of age. When ques-
tioned whether they would have obliged to obtain such 
immunization, they raised doubts as to whether such 
immunization is really necessary at their age. While only 
10 of themhad heard of measles, 8 thought it was an ill-
ness in the childhood and adults had nothing to do with 
it. Furthermore, two patients had regular foreign travel 
to regional countries for business or occupation related 
purposes, one had travelled to India on Buddhist pilgrim-
age several occasions over the last four years. None of 
the others have travelled outside the country. While one 
patient who arrived for follow up visit had become aware 
that the receptionist in his private company had been ill 
with a similar illness about two days prior to his illness, 
none of the others were aware of such illness among their 
work mates or among other associates. However they 
were travelling in public transport very often for daily 
needs. The last patient to be included in the cohort was a 
sister of a final year medical student who had been doing 
the paediatric clinical appointment at the time she devel-
oped the illness. 
Discussion
Eradication effort has to permanently eliminate a patho-
gen everywhere in the world thereby removing the risk 
of reintroduction and re-establishment. Elimination, on 
the other hand, focuses on reduction to zero incidence of 
a certain pathogen in a given area, with active measures 
to prevent pathogen re-establishment from other areas 
after elimination. During an elimination process, once 
an infection is driven to very low levels, the ecology of 
pathogens may change requiring different surveillance 
and control strategies [12]. Susceptible build-up, waning 
of immunity, increase in the age of infection, non-com-
pliance of individuals with control measures, pathogen 
change and emergence of resistance as a result of intensi-
fied efforts all become increasingly important during the 
final stages of such programmes [12]. Therefore, in order 
to achieve targets for elimination of vaccine preventable 
highly contagious illnesses such as measles, in addition to 
the maintenance of vaccination integrity, all other likely 
contributory factors for the illness in the community 
needs to be timely identified and intervened.
CNTH is the only tertiary care institution in the 
Gampaha district of the Western Province of Sri Lanka. 
Fig. 1 Red eyes in a patient with measles
Fig. 2 Maculopapular rash of measles
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Although it does not represent the status of hospi-
tals in the whole of Sri Lanka, Western Province or the 
Gampaha district, the two hospitals included here are 
likely to represent the basic infrastructure facilities that 
are available in most of the government hospitals and 
the private sector hospitals. Firstly, the adult patients 
who presented to both hospitals had at least 3–4  days 
of admission until the diagnosis was made. The patients 
who were admitted to CNTH were kept in a busy medi-
cal unit, among most other patients with either acute or 
chronic ill health. The reasons for the delay in the diag-
nosis included non-awareness of its occurrence, unfa-
miliarity of clinical illness among adults and non-specific 
nature of the clinical illness that mimicked any other 
common acute tropical febrile illness.
Since all these patients were above 25 years of age it is 
likely that they had no or partial immunization against 
measles by natural mechanisms or through National 
Immunization programme. During the acute phase of ill-
ness (first 4 days) all these patients presented with an ill-
ness that mimicked acute dengue or any other common 
acute febrile illnesses in the tropical setting. Although 
they were negative by NS1 antigen they were kept under 
close monitoring as almost all of them had reducing or 
low platelet counts and derangement in hepatic enzymes. 
Although the development of the facial rash together 
with red tearing eyes suggested the possibility of measles, 
its diagnosis was delayed at least in the first few patients 
due to unfamiliarity of the illness in adults. It mimicked 
chikungunya fever in some cases due to severe arthralgia 
and the non-specific nature of the rash and its pattern of 
involvement [13]. Furthermore, a similar clinical illness 
seems to occur in Zika virus infection [14] although it is 
yet to be documented in Sri Lanka.
Almost all of these patients were managed in a busy 
clinical setting and amongst other patients with acute or 
chronic illnesses such as diabetes mellitus, chronic liver 
disease or chronic kidney disease where immune defi-
ciency is known to occur. In multi-specialty tertiary care 
centers there is a possibility of transmission to immune-
compromised and pregnant patients as well as to non-
immune staff who may in turn care for high-risk patients 
[15]. Although we were not made aware of any occurrence 
of measles among patients or the ward staff who had close 
contact during the management of these patients, influx 
of patients with measles to busy multidisciplinary tertiary 
care centers during community outbreaks of measles have 
resulted in nosocomial outbreaks [16, 17].
Early diagnosis of measles and isolation of such 
patients would be the most ideal strategy in order to 
prevent spread and occurrence of spread to other non-
immune patients or health care workers. However cur-
rently there are no early diagnostic facilities available for 
measles and there are no isolation facilities available in 
CNTH or most other major hospitals in Sri Lanka. Fur-
thermore, it is very unlikely that such facilities would be 
realistic in most hospitalsof developing countries such 
as Sri Lanka. It is well known that acute febrile illnesses 
that occur in the tropics such as measles, dengue fever, 
typhoid fever, leptospirosis, and severe acute respira-
tory syndrome (SARS) can be confused with each other 
[18]. At presentation, these febrile illnesses share similar 
clinical features, including headache, myalgia, and rash. 
In the case of dengue fever clinical features of dengue 
haemorrhagic fever, such as bleeding and plasma leakage, 
are seen after the initial febrile phase is subsiding, typi-
cally after the third or fourth day of fever. Similarly rash 
of measles although non-specific, appears after the 4th 
day of the illness. Therefore illnesses with similar charac-
teristics, such as dengue, leptospirosis, measles, etc. have 
been found difficult to discriminate on the basis of any 
clinical algorithm alone [18]. Therefore, the most impor-
tant strategy to diagnose measles at a very early stage 
would be to develop molecular/antigen based rapid diag-
nostics with high sensitivity and specificity. However, it 
is very unlikely that such diagnostics would be developed 
and made available, cost effective or realistic for illnesses 
such as measles due to its low incidence and low mortal-
ity figures.
Although the most likely reason for measles infec-
tions in these adult patients would be the on-going low 
level measles infection in the community, we feel that it 
is important to consider other likely source of the mea-
sles virus especially in the adults. Such sources could 
be related to acquisition of the virus through foreign 
travel although none of these patients or their close con-
tacts had a history of foreign travel closer to their being 
ill. This is because such infection is likely to introduce 
non-native genotypes of the virus resulting in severe 
outbreaks [19]. Furthermore potential for introduction 
of new virus-genotypes should be kept in mind asworld 
travel is rapidly expanding for many purposes such as 
for education, employment and tourism. Travel has been 
shown to cause importation of infections such as SARS, 
chikungunya, dengue and Zika virus to many parts of the 
world resulting in outbreaks or establishment of these 
infections in various geographical regions [20, 21]. There-
fore, there is always a risk of transmission of illnesses like 
measles between countries.
The combination of molecular epidemiology and 
standard case classification and reporting seems to be 
very sensitive means to describe the transmission path-
ways of measles. Virologic surveillance in order to moni-
tor the viral genotypes in a particular country or region 
over time seems very important in order to interrupt 
the transmission of endemic measles [22]. In order to 
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address these issues, the Epidemiology Unit of Sri Lanka 
has implemented due measures to obtain comprehen-
sive data collection from patients with measles includ-
ing obtaining blood samples for genetic isolations [23]. 
However, it was noted that such operations have either 
been unaware of or slowed down due to sporadic nature 
of measles among the adult patients (unpublished data). 
Therefore, intensified public awareness, periodic remind-
ing of medical institutions and implementation of proper 
monitoring systems may be warranted in order to achieve 
current goals towards elimination of measles by the year 
2020.
Conclusion
In conclusion, clinicians who deal with adult patients 
should be made aware of the possibility of measles infec-
tion among acute febrile illness and be reminded of the 
symptomatology of measles in adults. Furthermore, it 
would be essential to understand the community impli-
cations of these sporadic cases of adult measles towards 
the ongoing efforts on eradication of measles both locally 
and globally. While availability of early diagnostic facili-
ties would help in management of patients, isolation of 
the virus and genotyping are likely to play an important 
role in implementing effective immunization and help 
achieving the targeted elimination of measles by the year 
2020.
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